PPI2R5B-T1: A Promising Drug Target for Cell Survival AndApoptosis Regulation

Target Name: PPP2R5B

NCBI ID: G5526

PPP2R5B

PPI2R5B-T1: A Promising Drug Target for Cell Survival AndApoptosis Regulation

PPI2R5B (B56beta), also known as PPI2R5B-T1, is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the PPI2R5 family, which is known for its role in intracellular signaling. The B56beta subunit of PPI2R5B has been shown to play a unique role in the regulation of cellular processes, including cell survival, apoptosis, and inflammation.

The search for potential drug targets has become a major focus in recent years, and PPI2R5B-T1 has generated a lot of interest due to its unique biology and potential contributions to various diseases. One of the key challenges in studying PPI2R5B-T1 is its complex structure and the difficulty in predicting its function in different contexts. However, recent studies have provided some insights into the biology of PPI2R5B-T1 and its potential as a drug target.

Expression and Localization

PPI2R5B-T1 is a cytoplasmic protein that is expressed in a variety of tissues, including the brain, heart, liver, and kidneys. It is predominantly expressed in the brain, where it is found in the endoplasmic reticulum (ER) and in the cytoplasm. PPI2R5B-T1 has also been shown to be expressed in other tissues, including the liver, heart, and kidneys.

The localization of PPI2R5B-T1 is well understood. It is predominantly cytoplasmic, but it can also be found in the ER and in the cytoplasm. The protein is thought to be involved in the regulation of various cellular processes, including cell survival, apoptosis, and inflammation.

Function and Interaction

PPI2R5B-T1 is a member of the PPI2R5 family, which is known for its role in intracellular signaling. The PPI2R5 family consists of six subunits, including B56, B55, B54, B53, B52, and B51. The B56beta subunit of PPI2R5B-T1 has unique functions in various cellular processes.

One of the key functions of PPI2R5B-T1 is its role in cell survival. The protein has been shown to regulate cell survival by preventing apoptosis. In addition, the B56beta subunit of PPI2R5B-T1 has been shown to promote cell survival by increasing the expression of Bcl-2, a protein that can prevent cell apoptosis.

Another function of PPI2R5B-T1 is its role in apoptosis. The protein has been shown to regulate apoptosis by preventing the release of pro-apoptotic proteins. In addition, the B56beta subunit of PPI2R5B-T1 has been shown to promote the execution of apoptosis by increasing the production of reactive oxygen species (ROS).

In addition to its role in cell survival, PPI2R5B-T1 is also involved in inflammation. The protein has been shown to regulate inflammation by preventing the production of pro-inflammatory cytokines.

Drug Targets

The unique biology of PPI2R5B-T1 has made it an attractive target for drug development. Several drugs, including inhibitors of PPI2R5B-T1, have been shown to be effective in treating various diseases.

One of the most promising drugs is a small molecule inhibitor of PPI2R5B-T1, known as B56- inhibitor. This drug has been shown to be effective in treating

Protein Name: Protein Phosphatase 2 Regulatory Subunit B'beta

Functions: As the regulatory component of the serine/threonine-protein phosphatase 2A (PP2A) holoenzyme, modulates substrate specificity, subcellular localization, and responsiveness to phosphorylation. The phosphorylated form mediates the interaction between PP2A and AKT1, leading to AKT1 dephosphorylation

The "PPP2R5B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP2R5B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets